Artificial Intelligence

PatentNext Blog

PatentNext is a weblog (“Blog”) about Patent and Intellectual Property (IP) law focusing on Next-generation and New Age technologies.

Recent Blog Posts

• Federal Circuit finds Generic Artificial Intelligence (AI) Claims Abstract PatentNext Summary: The Federal Circuit’s decision in Recentive Analytics, Inc. v. Fox Corp. found that applying generic machine learning techniques to a new environment, without a specific technological improvement, is patent-ineligible under 35 U.S.C. § 101. The court emphasized that claims must articulate concrete technological advancements rather than merely applying established methods to different domains. The ruling offers key guidance for patent practitioners, highlighting the need for detailed descriptions of technical innovation and cautioning against relying on field-of-use limitations or... More
• Quantum Computing Patent Trends in the US: Are Breakthroughs Just Around the Corner? Recent headlines suggest that prominent technology CEOs are tossing tepid water onto the quantum computing narrative, leading to a sell-off of quantum computing stocks in January 2025. However, quantum computing CEO’s disagree, asserting that commercial quantum computers are already here and delivering value to clients. While the timeline for widespread quantum utility remains debated, one thing is undeniable: innovation in quantum computing is accelerating, and the evidence is clearly visible in the patent landscape. Understanding these patent trends offers a... More
• PTAB Provides Some Clarity on Artificial Intelligence (AI) Obviousness in IPR Decision In a recent PTABWatch article titled “PTAB Provides Some Clarity on Artificial intelligence (AI) Obviousness in IPR decision,” the PTAB’s approach to evaluating obviousness in AI-related patents is examined.  The article discusses the case Tesla, Inc. v. Autonomous Devices, LLC, where the PTAB invalidated all challenged claims of U.S. Patent Number 11,055,583, which pertained to an AI system for autonomous device operation.  The decision offers valuable insights into how prior art is assessed in the context of AI innovations.  Read... More
• Agentic AI: Transforming Industries and Navigating the Patent Frontier Agentic AI is transforming artificial intelligence by enabling systems to act independently, making decisions and solving problems autonomously across various industries. Its potential rapid development poses unique challenges for intellectual property protection, requiring innovative strategies to ensure these advancements are effectively safeguarded within the evolving IP landscape. Introduction Last year, we explored how Multimodal AI, integrating multiple sensory modalities, continues to revolutionize human-machine interaction and spark discussions on its implications. This year, the focus shifts to Agentic AI—systems capable of autonomous decision-making,... More
• Generative Artificial Intelligence (AI) Patent Application Filings See Early Growth Trend at the USPTO PatentNext Summary: Generative Artificial Intelligence (GenAI) patent application filings continue to rise at the U.S. Patent and Trademark Office (USPTO), with a significant concentration in Tech Center 2100, which focuses on computer architecture and software, particularly AI and simulation technologies. GenAI inventions commonly face Section 103 (obviousness) and Section 101 (subject matter eligibility) rejections, with the latter being a frequent challenge for computer-related inventions. Despite this, Tech Center 2100 boasts a relatively high allowance rate of 79%, while other centers,... More
• AI-based Inventions: Patenting vs. Trade Secret Considerations PatentNext Takeaway: When deciding whether to patent AI-based inventions or maintain them as trade secrets, key considerations include the extent of public disclosure and the detectability of the AI model. Deploying an AI model in consumer-facing devices or making its output public often supports patenting to secure exclusivity. On the other hand, low detectability and sensitive training data, such as personal or medical information, may favor trade secret protection. Balancing these factors alongside the need for sufficient disclosure to meet... More
• Drafting Software-based Patent Claims to Avoid Costly Divided Infringement Issues This article is co-authored by Phelan Simpkins, counsel for State Farm who oversees emerging technology licenses, among other key areas for the company. Phelan is speaking in his individual capacity. The views expressed herein do not necessarily reflect the view and position of State Farm. PatentNext Takeaway: This post discusses the issues of divided infringement in U.S. patent law, specifically focusing on software-based patent claims. Divided infringement occurs when multiple parties collectively perform all the steps of a patent claim, but... More
• AI-based Medical Devices and the FDA’s Predetermined Change Control Plans (PCCPs) PatentNext Takeaway: This post highlights the FDA’s increasing regulatory efforts for artificial intelligence (AI) and machine learning (ML)-enabled medical devices (MLMDs), with a focus on managing device AI/ML updates through Predetermined Change Control Plans (PCCPs). The FDA emphasizes five guiding principles for PCCPs to ensure safety, risk management, and transparency for MLMDs throughout their lifecycle. The post also notes a significant rise in AI-based medical device FDA submissions and related patent filings, particularly since 2016, indicating growing interest in this... More
• WIPO Issues a Patent Landscape Report on Generative Artificial Intelligence (GenAI) PatentNext Takeaway:  WIPO published a Patent Landscape Report on GenAI.  The Patent Landscape Report discusses trends in GenAI, including trends in: GenAI scientific publications, GenAI patents, GenAI models, types of data used in GenAI, and GenAI application areas. **** GenAI Scientific Publications and Patent Families There has been a sharp increase in the number of patent families over the past 10 years.  Specifically, GenAI has grown from 733 in 2014 to more than 14,000 in 2023.   This rise of GenAI has been mainly... More
• The USPTO Issues Guidance on Patenting Artificial Intelligence (AI)-related Inventions per 35 U.S.C. § 101 (Subject Matter Eligibility) PatentNext Takeaway: The USPTO announced its 2024 Guidance Update on Patent Subject Matter Eligibility, particularly focusing on Artificial Intelligence (AI). Effective July 17, 2024, this guidance aims to address examination procedures for U.S. patent applications under 35 U.S.C. § 101, following President Biden’s executive order on the safe development and use of AI. The 2024 AI Guidance is designed to help USPTO personnel apply existing subject matter eligibility rules to AI-related inventions during patent examination, appeal, and post-grant proceedings. It... More